Insights

Established Market Presence Bilim Pharmaceuticals operates with a substantial workforce of up to 5,000 employees and generates significant revenue between 1 billion and 10 billion USD, indicating a strong position within the pharmaceutical manufacturing sector and potential for large-scale procurement opportunities.

Growing Industry Footprint Similar companies such as Hovione and Krka demonstrate the company's alignment within a competitive landscape characterized by established players with extensive global reach, suggesting opportunities for partnership or supply chain expansion.

Diverse Technology Stack The company's utilization of advanced software and tools like MySQL, PHP, and Microsoft IIS reflects an emphasis on modern technological infrastructure, providing opportunities for collaborations in digital solutions or tech-enabled services to optimize manufacturing and operational efficiency.

Financial Robustness With a robust revenue stream, Bilim Pharmaceuticals may be interested in innovative product development, technology upgrades, or infrastructure investments, creating sales opportunities in R&D support, manufacturing technologies, or clinical services.

Market Expansion Potential Based in Istanbul and part of a vibrant pharmaceutical sector, the company is positioned well for regional expansion and international partnerships, offering prospects for sales of regulatory consulting, distribution channels, or new product lines to support growth initiatives.

Similar companies to Bilim Pharmaceuticals

Bilim Pharmaceuticals Tech Stack

Bilim Pharmaceuticals uses 8 technology products and services including MySQL, Font Awesome, Select2, and more. Explore Bilim Pharmaceuticals's tech stack below.

MySQL
Database
Font Awesome
Font Scripts
Select2
Javascript Libraries
Slider Revolution
Miscellaneous
PHP
Programming Languages
Minitab
Visualisation Software
X-Content-Type-Options
Web & Portal Technology
Microsoft IIS
Web Servers

Media & News

Bilim Pharmaceuticals's Email Address Formats

Bilim Pharmaceuticals uses at least 1 format(s):

Bilim Pharmaceuticals Email Formats	Example	Percentage
First.Last@bilimilac.com.tr	John.Doe@bilimilac.com.tr	72%
LastFirst@bilimilac.com.tr	DoeJohn@bilimilac.com.tr	20%
FLast@bilimilac.com.tr	JDoe@bilimilac.com.tr	7%
Last@bilimilac.com.tr	Doe@bilimilac.com.tr	1%

Frequently Asked Questions

Where is Bilim Pharmaceuticals's headquarters located?

Bilim Pharmaceuticals's main headquarters is located at Maslak Mah. Sumer sokak, no:4 istanbul, 34398, TR. The company has employees across 4 continents, including AsiaAfricaEurope.

What is Bilim Pharmaceuticals's official website and social media links?

Bilim Pharmaceuticals's official website is bilimilac.com.tr and has social profiles on LinkedIn.

What is Bilim Pharmaceuticals's NAICS code?

Bilim Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bilim Pharmaceuticals have currently?

As of October 2025, Bilim Pharmaceuticals has approximately 1K employees across 4 continents, including AsiaAfricaEurope. Key team members include Finance Director: T. K.Administrative Affairs And Fleet Manager: B. C.Field Force Manager: G. Y.. Explore Bilim Pharmaceuticals's employee directory with LeadIQ.

What industry does Bilim Pharmaceuticals belong to?

Bilim Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Bilim Pharmaceuticals use?

Bilim Pharmaceuticals's tech stack includes MySQLFont AwesomeSelect2Slider RevolutionPHPMinitabX-Content-Type-OptionsMicrosoft IIS.

What is Bilim Pharmaceuticals's email format?

Bilim Pharmaceuticals's email format typically follows the pattern of First.Last@bilimilac.com.tr. Find more Bilim Pharmaceuticals email formats with LeadIQ.

When was Bilim Pharmaceuticals founded?

Bilim Pharmaceuticals was founded in 1953.

Bilim Pharmaceuticals

Pharmaceutical ManufacturingTurkey1001-5000 Employees

bilim calisanlarının biraraya geldigi , resmi olmayan paylasım platformudur.
Kurumu resmi olarak  temsil etmemektedir.























non-official sharing platform...

................................................................................................................................................................